# MOTS-c peptide FAQ: Side Effects, Dosing, Safety, and Legal Questions > MOTS-c peptide FAQ: direct, cited answers on side effects, weight, liver questions, timelines, legality, and compounding — grounded in the preclinical and regulatory record. Direct answers, cited where the claim is quantitative, honest where the human evidence runs out. ## Does MOTS-c affect bone density or osteoporosis? In ovariectomized mice, MOTS-c (5 mg/kg/day IP, 12 weeks) suppressed bone loss by inhibiting RANKL-driven osteoclast differentiation via AMPK [5]; osteoblast and TGF-beta/SMAD collagen effects are reported in osteoporosis models [8]. All of this evidence is preclinical — there is no human bone-density data. ## What does the MOTS-c peptide do? MOTS-c is a 16-amino-acid mitochondrial-derived peptide that inhibits the folate cycle, raises AICAR, and activates AMPK, improving glucose handling and insulin sensitivity in skeletal muscle in animal models [1]. Under stress it also moves into the nucleus to regulate gene expression [3]. ## What are the negative side effects of MOTS-c? No human safety trials of exogenous MOTS-c have been completed, so a side-effect profile is not established; the published work is preclinical or observational biomarker data [4][12]. The documented concerns are evidentiary — no human data, unvalidated pharmacokinetics, and unregulated research-chemical purity — rather than a catalogued list of adverse events. ## Is MOTS-c legal to buy? MOTS-c is not FDA-approved and is sold only as a research chemical for laboratory use; it has no approved human indication or formulation [1][17]. It is named on the FDA's July 2026 PCAC agenda as a substance under evaluation for the 503A bulks list — a scheduled discussion, not a change in status [19]. ## How often do you inject MOTS-c? There is no human dosing schedule. Rodent studies used daily or thrice-weekly intraperitoneal injection (for example, 0.5-15 mg/kg/day IP) [1][2]; these are animal-research regimens, not human guidance, and no human dosing frequency has been validated [4]. ## Can MOTS-c cause weight gain? In mice, MOTS-c prevented diet-induced obesity rather than promoting weight gain [1]; no human weight data exist, so the question cannot be answered clinically [4]. The animal evidence points the opposite direction from weight gain, but it does not establish a human effect. ## Is MOTS-c hard on the liver? No human hepatic-safety data have been published for exogenous MOTS-c; the available literature is preclinical and does not characterize liver effects in humans [4][12]. Any claim about liver impact in people would be unsupported by the current record. ## What are the downsides of MOTS-c? The main limitation is evidentiary: no completed human efficacy or safety trials, no validated human pharmacokinetics, and unregulated research-chemical purity across suppliers [4][12]. MOTS-c is also treated as a prohibited substance in elite sport by anti-doping bodies [12]. ## Can I get MOTS-c over the counter? No. MOTS-c is not an approved drug or dietary supplement; it is offered only for laboratory research, not as an over-the-counter product [17]. There is no legal over-the-counter human formulation of MOTS-c. ## How long does it take for MOTS-c to kick in? No human onset data exist. In mice, a single dose improved acute exercise performance and chronic dosing improved metabolic measures over weeks [1][2], but timelines are species- and study-specific and do not translate to people. ## What are the potential benefits of MOTS-c? In animal and cell research, MOTS-c has been associated with improved insulin sensitivity, prevention of diet-induced obesity, enhanced physical capacity, and muscle and bone preservation [1][2][5]; none of these are established human benefits because no human efficacy trial has been completed [4]. ## How does MOTS-c make you feel? There are no controlled human experience data; subjective effects are not characterized in the peer-reviewed literature, which is preclinical or observational [4][12]. Any reported "feel" is anecdotal and outside the published evidence base. ## How long does MOTS-c take to work? Rodent metabolic effects emerged over chronic dosing across weeks, while a single dose acutely improved exercise capacity [1][2]; no human timeline has been measured. Onset in people is simply unknown. ## Does MOTS-c burn fat? In mice, MOTS-c increased adipose thermogenesis and prevented diet-induced obesity [1], and human biomarker studies link lower circulating MOTS-c to obesity [4]. This is associative and preclinical — not a demonstrated human fat-loss effect. ## Can I inject MOTS-c every day? Daily intraperitoneal dosing was used in some mouse studies [1], but no human dosing frequency has been established or validated [4]; rodent regimens are not human guidance. There is no human protocol of any frequency. ## How long should you take MOTS-c? Study durations ranged from days to 12 weeks in animals [1][5]; there is no human treatment-duration recommendation because no human trials have been completed [4]. Duration in people is undefined. ## Is MOTS-c bad for the liver? No human hepatic data exist; the literature is preclinical and does not address liver safety in people [4][12]. The record neither supports nor rules out a human liver effect — it simply has not been studied. ## Does MOTS-c work immediately? A single dose acutely improved exercise performance in mice, but metabolic effects in animals built over repeated dosing [1][2]; no immediate-effect data exist for humans. "Immediate" effects in people are uncharacterized. ## Is MOTS-c legal? MOTS-c is a research peptide and is not FDA-approved for any indication; it is sold only as a research chemical for laboratory use [1][17]. It is named on the FDA's July 2026 PCAC agenda as a substance under evaluation for the 503A bulks list — a scheduled discussion, not a change in status [19]. ## Can you get MOTS-c from a compounding pharmacy? Not as a matter of routine. A 503A pharmacy may use a bulk substance only if it has a USP/NF monograph, is a component of an approved drug, or is on FDA's 503A bulks list [17]. MOTS-c is none of these; it is under PCAC evaluation, not on the list [17][19], and any lawful access still requires a valid prescription [18]. ## What is the FDA 503A status of MOTS-c? MOTS-c is not on FDA's 503A bulks list and is not an FDA-approved drug; it is a bulk drug substance scheduled for evaluation by the Pharmacy Compounding Advisory Committee at the July 23-24, 2026 meeting [17][19]. The audited reference assigns it no numbered 503A category, so none is stated here [19]. --- A vivid market-stall review of the MOTS-c literature — each metabolism, exercise and bone study set out on its own painted card and cited to source, the empty human-trial line left in plain view, and the FDA 503A standing read off the PCAC agenda; no clinic behind the stall and nothing here dispensed or sold.